Showing results (151-160 of 402) with videos related to
Sort By:
Pageof 41
Plos One|June 19, 2015
Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary CancersLuisa Carbognin, Sara Pilotto, Michele Milella, et al.Journal of the American Geriatrics Society|November 15, 2017
Hepatitis C Virus Clearance in Older AdultsAntonio Massimo Ippolito, Angelo Iacobellis, Michele Milella, et al.Critical Reviews in Oncology/Hematology|September 8, 2014
Progression-free survival as primary endpoint in randomized clinical trials of targeted agents for advanced renal cell carcinoma. Correlation with overall survival, benchmarking and power analysisEmilio Bria, Francesco Massari, Francesca Maines, et al.Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 5, 2025
Effect of exercise on bone-related outcomes in patients with cancer affected by bone metastases or bone loss: a systematic review and meta-analysisAnita Borsati, Gloria Adamoli, Diana Giannarelli, et al.Clinical Genitourinary Cancer|January 28, 2024
PARP Inhibitors in Metastatic Prostate Cancer: A Comprehensive Systematic Review and Meta-analysis of Existing EvidenceFrancesco Ditonno, Alberto Bianchi, Sarah Malandra, et al.BMC Cancer|November 26, 2022
Multicentre, randomised, open-label, parallel-group, clinical phase II study to evaluate immunonutrition in improving efficacy of immunotherapy in patients with metastatic non-small cell lung cancer, undergoing systematic nutritional counselingRiccardo Caccialanza, Emanuele Cereda, Francesco Agustoni, et al.Anticancer Research|September 29, 2020
Predictors of Local Control for Stereotactic Ablative Radiotherapy (SAbR) in Pulmonary Oligometastases from Gastrointestinal MalignanciesNicola Simoni, Renato Micera, Gabriella Rossi, et al.Cancer Treatment Reviews|March 20, 2023
Secondary prevention and treatment innovation of early stage non-small cell lung cancer: Impact on diagnostic-therapeutic pathway from a multidisciplinary perspectiveGiulia Pasello, Daniela Scattolin, Laura Bonanno, et al.Frontiers in Oncology|January 28, 2025
A cross-sectional study exploring the perception of exercise oncology in the Italian populationAnita Borsati, Diana Giannarelli, Giampaolo Pase, et al.Endocrine|November 18, 2023
The endocrine disruptor cadmium modulates the androgen-estrogen receptors ratio and induces inflammatory cytokines in luminal (A) cell models of breast cancerViviana M Bimonte, Giuseppina Catanzaro, Agnese Po, et al.Pageof 41